2016
DOI: 10.1080/02813432.2016.1183692
|View full text |Cite
|
Sign up to set email alerts
|

Increased consultation frequency in primary care, a risk marker for cancer: a case–control study

Abstract: ObjectiveTo identify early diagnostic profiles such as diagnostic codes and consultation patterns of cancer patients in primary care one year prior to cancer diagnosis.DesignTotal population-based case–control study.Setting and subjects4562 cancer patients and 17,979 controls matched by age, sex, and primary care unit. Data were collected from the Swedish Cancer Register and the Regional Healthcare Database.MethodWe identified cancer patients in the Västra Götaland Region of Sweden diagnosed in 2011 with prost… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
23
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(27 citation statements)
references
References 29 publications
4
23
0
Order By: Relevance
“…Most patients with lung cancer first present to their general practitioner (GP) [ 13 16 ]. Lung cancer often presents with symptoms that are very commonly encountered in primary care, making early diagnosis challenging.…”
Section: Introductionmentioning
confidence: 99%
“…Most patients with lung cancer first present to their general practitioner (GP) [ 13 16 ]. Lung cancer often presents with symptoms that are very commonly encountered in primary care, making early diagnosis challenging.…”
Section: Introductionmentioning
confidence: 99%
“…[21,26,27]. Consultancy frequency represents another criterion of interest for further study; an increased frequency of consultancies has been documented during the year prior to a diagnosis of cancer [28,29]. This criterion has been included among the Danish cancer patient pathway referral criteria for patients with nonspecific symptoms [23].…”
Section: Discussionmentioning
confidence: 99%
“…Our findings of symptom prevalence across a representative cohort of patients diagnosed with 1 of 28 cancer sites substantially augment previous evidence dominated by cancer site-specific symptom studies. 25 27 , 30 , 34 …”
Section: Discussionmentioning
confidence: 99%